New Alzheimer’s drug faces challenges
(By Alexandra Murphy for Becker’s Hospital Review ) Leqembi, an Alzheimer’s drug from Biogen and Eisai, faces hurdles with respect
Read More(By Alexandra Murphy for Becker’s Hospital Review ) Leqembi, an Alzheimer’s drug from Biogen and Eisai, faces hurdles with respect
Read More(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch
Read More(By Jakob Emerson for Becker’s Hospital Review ) The trend of health insurers launching products without traditional deductibles is accelerating,
Read More(By Samantha Liss and Rachana Pradhan for KFF Health News) The computer systems run by the consulting giant Deloitte that
Read More(By Juliana Kim, Tim Evans for NPR) RUGBY, N.D. — Cindie Haakenson was relieved when a room opened up at
Read More(By Fred Schulte for KFF Health News) A decade ago, federal officials drafted a plan to discourage Medicare Advantage health
Read More(By Imani Telesford, Aubrey Winger, and Matthew Rae for The Kaiser Family Foundation published August 22, 2024) Most adults (91%)
Read More(By Jakob Emerson for Becker’s Hospital Review ) As healthcare costs continue to rise, a growing number of employers are
Read More(By Mariah Taylor for Becker’s Hospital Review ) Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare
Read More(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More